Narrow beam dosimetry for high-energy hadrons and electrons by Pelliccioni, M et al.
EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH
European Laboratory For Particle Physics
CERN-TIS-2001-009-RP-PP
Narrow beam dosimetry for high-energy hadrons and electrons
Maurizio Pelliccioni (1), Marco Silari (2) and Luisa Ulrici (2)
(1) INFN, Laboratori Nazionali di Frascati, 00044 Frascati, Italy
(2) CERN, 1211 Geneva 23, Switzerland
Abstract
Organ doses and effective dose were calculated with the latest version of the Monte
Carlo transport code FLUKA in the case of an anthropomorphic mathematical model
exposed to monoenergetic narrow beams of protons, pions and electrons in the energy
range 10˚— 400 GeV. The target organs considered were right eye, thyroid, thymus,
lung and breast. Simple scaling laws to the calculated values are given. The present
data and formula should prove useful for dosimetric estimations in case of accidental
exposures to high-energy beams.
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Data for protection against ionising radiation from external sources are usually
expressed in terms of conversion coefficients from measurable quantities (such as
particle fluence or air kerma) to protection quantities (such as effective dose and organ
dose), calculated in various geometrical conditions of irradiation of human body.
Typical irradiation conditions are infinite plane-parallel beam or isotropic beam
impinging on an anthropomorphic mathematical model (a phantom ). When an
assessment of partial exposures of human body is required, which is typical of an
accidental irradiation, the broad-beam data are inadequate. In particular, their
application to narrow beam exposures leads to (possibly large) errors in the estimates
of the body quantities, the degree of which depends on the irradiation geometry and on
type and energy of incident radiation.
Although unlikely, such an accidental situation may occur at particle accelerator
facilities. Exposures to gas bremsstrahlung and to synchrotron radiation beams as well
as to primary and secondary particle beams are typical circumstances in which data for
narrow beam dosimetry are needed. Data have recently been made available for gas
bremsstrahlung (1,2) as well as photon, electron and proton beams up to 10˚GeV (3), but
estimates for higher energy particles are missing. These data are important for high-
energy research laboratories such as CERN, where mixed beams with energy up to
400˚GeV are available.
The CERN Super Proton Synchrotron (SPS) accelerates protons to 400 GeV,
which are then simultaneously extracted from two regions in the machine and directed
to several targets. These targets produce secondary and tertiary beams serving a
number of experiments and test areas installed in four experimental halls. Various
combinations of secondary beams are available; the beams may have positive or
negative momentum and be composed of a mixture of particles, namely protons,
positive and negative pions, kaons, electrons and muons. The maximum secondary
beam intensity is of the order of 108 particles per SPS pulse, i.e. every 14.4˚s, but in
practice most of the experiments run with lower intensities (typically in the range 106 to
107 particles per pulse). The beam composition depends on its energy. A positive
secondary beam typically consists of about 80% positive pions and 20% protons at
40˚GeV, 2/3 positive pions and 1/3 protons at 100 GeV, 2/3 protons and 1/3 positive
pions at 200˚GeV and protons at 400˚GeV, with a small kaon component (a few per
cent). Useful electron beams are typically limited to a maximum energy of 200 GeV, as
above this energy the beam intensity drops drastically to below 104 particles/pulse, but
higher energies are nevertheless possible. Muons are not really focussed into narrow
beams. Due to the maximum allowable beam intensities, the beam lines and the
experimental areas are fenced off by grids and shielding blocks, but are not top
shielded. Access is interlocked to beam operation and is controlled by a one key — one
person procedure, but it is left on self-service  to the users. Thus while exposure to the
primary proton beam circulating in the SPS cannot occur, an accidental scenario
involving personnel exposure to a secondary beam cannot a˚priori be excluded. Data
for narrow beam dosimetry for hadrons and electrons with energy up to several
hundreds of GeV may therefore be useful.
The effective dose is not an adequate risk indicator in the case of partial
irradiation. It is unable to take into account the incidence of deterministic effects and is
not meant for that. Both effective dose and organ dose in the exposed tissue or organ
need therefore to be considered. The absorbed dose in the organ accounts for
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threshold is not approached, the effective dose accounts for the probability of stochastic
effects. This paper provides values of effective dose and absorbed doses in various
organs due to narrow beams of protons, pions and electrons in the energy range
10˚—˚400˚GeV. Simple scaling laws are derived for application in post-accident
dosimetry.
2. Monte Carlo calculations
Calculations were carried out with the latest version of the FLUKA Monte
Carlo transport code˚(4-7) (FLUKA2000)˚(8) and a hermaphrodite mathematical
model˚(9,10). A feature relevant to the present work is that the breast is only present on
the right half of the phantom. When the breast is the target organ, the underlying lung is
simultaneously irradiated. When the lung is selected as target organ, the beam is
directed to the left half of the phantom.
Since the protection quantities were proven to be slightly dependent on the
beam size of a narrow beam (11,12), calculations were performed with a pencil beam with
no physical dimensions. A monoenergetic pencil beam of electrons, protons, positive or
negative pions impinged in the centre of a given organ or tissue (target organ) of the
phantom. Five representative organs were chosen as a target, namely right eye, thyroid,
thymus, breast and lung. These organs were selected on the basis of their specific
radiosensitivity as well as of the probability of irradiation in the event of an accidental
exposure. The radiosensitivity is taken into account by the tissue weighting factor wT, a
factor by which the equivalent dose to a tissue or organ is multiplied in order to account
for the relative stochastic detriment resulting from the exposure of different tissues and
organs. Here it was assumed that the wT-values recommended by ICRP 60˚
(13) are
applicable in the case of narrow beam exposure. Thyroid is an organ having a specific
tissue weighting factor (wT˚=˚0.05), whilst the eye is an example of organ with no
specific weighting factor. Breast and lung have specific weighting factor (wT˚=˚0.05 and
wT˚=˚0.12, respectively) and represent the case of two organs simultaneously irradiated
as target organs by penetrating radiation. Thymus is part of the remainder. These five
target organs should provide a fairly comprehensive picture of possible irradiation
conditions and the results used for a radiological estimation in case of a real accidental
exposure where a different organ may be involved. Both the dose to the target organs,
DT, and the effective dose, E, were calculated.
The probability of stochastic effects also depends on the type and energy of the
incident radiation. This is taken into account by weighting the absorbed dose by a
factor wR (radiation weighting factor) related to the quality of the radiation. For protons
it is wR˚=˚5, for electrons wR˚=˚1 
(13), for positive and negative pions wR˚=˚2 
(14). We
have assumed 5 for protons since this is the value recommended by ICRP, but at very
high energies a value of 1 or 2 would be more appropriate˚(14).
Simulations were performed for beam energies of 10, 20, 50, 100, 200 and
400˚GeV. The energy per primary particle deposited in the 68 regions of the phantom,
representing the various organs and tissues of the human body, was scored. The organ
doses were estimated as arithmetic mean of the doses received by the single constituent
regions. The effective dose was calculated according to the definition given in ICRP
Publication 60˚(13), as modified in ICRP Publication 69˚(15). The statistical uncertainties
were estimated by making calculations in several batches and by computing the
standard deviation of the mean. The total number of histories was large enough to keep
the standard deviation below a few per mil for DT and below a few per cent for E.
3. Results and discussion
The organ doses and the effective dose for the various target organs and
incident particles are given in Tables 1˚—˚4 and plotted as a function of energy in
Figures˚1˚—˚8. Tables˚1˚—˚4 list, for the various incident energies and target organs:
effective dose, dose to the target organ, ratio of target organ dose to effective dose,
weighted target dose (wTÆwRÆDT) and fractional contribution to effective dose of organs
different from the target organ. Figures˚1˚—˚8 also show the fits to the calculated values
according to the empirical law:
DT = AD + BD log K (Gy per primary particle)
and (1)
E = AE + BE log K (Sv per primary particle)
where K is numerically equal to the energy of the primary particle (proton, pion or
electron) in GeV. The parameters of the fits for the various target organs are given in
Tables 5˚—˚8. It should be underlined that expressions (1) have no physical meaning and
are only meant as a computational help.
Several considerations can be made by looking at the above tables and graphs.
First of all, the results for positive and negative pions are very similar. This is not
surprising, since the difference in the interaction of pions of opposite sign with matter
is in the capture of negative pions at the end of their range. This phenomenon is not
relevant in the present case as the beam energy is high enough that the particles are not
stopped in the body. For electrons, the second terms in equations (1) can in a first
approximation be neglected, as is seen from Table 4 and Figures 4 and 8.
When either the thymus or the eye is the target, the most irradiated organ is a
remainder, respectively the thymus itself or the brain. In these two cases the effective
dose E was calculated by attributing wT˚=˚0.025 to that specific remainder and
wT˚=˚0.025 to the average dose in the rest of the remainder (according to footnote 3 in
table 2 of ref. (13)). The application of this rule (which under broad-beam irradiation can
be disregarded) has certain consequences on the results. If one would neglect such a
rule and calculate E as for a broad-beam irradiation, one would underestimate the
effective dose by a constant factor of about 1.6 for protons and pions of both signs of
all energies irradiating the eye, by a factor ranging from 2.7 at 10˚GeV to 2.1 at
400˚GeV for protons irradiating the thymus, and by a factor from 2.7 at 10˚GeV to 2.2
at 400˚GeV for pions of both signs irradiating the thymus.
It should be mentioned that the present results for 10˚GeV protons and electrons
irradiating thyroid and breast cannot be directly compared with the analogous data (the
upper energy limit) of ref. (3), as here the beam was shot at the centre of the target
organ, unlike in ref. (3) where the beam was off-centre. Similarly, data in the last
column of Tables 1 and 4 cannot be directly compared with values in Tables 2 and 3 of
ref. (3), as in the present paper the weighted target dose (wTÆwRÆDT) also includes the
wR-factor, which was not the case in ref. 
(3).
Figures˚1˚—˚4 show that organ doses generally decrease significantly with
increasing organ mass, with irradiation of the eye giving the highest values. Since
thymus and thyroid have approximately the same mass, the difference in their absorbed
doses can only be imputed to either the organ geometry (the thyroid is represented as a
sphere, the thymus as an ellipsoid) or their position in the body. The beam traverses the
thymus along its minor axis, which is smaller than the diameter of the thyroid.
Table 1. Dosimetric quantities per primary proton as a function of incident energy for



























10 1.42 10-12 3.47 10-10 2.45 102 - 1
20 1.59 10-12 3.55 10-10 2.24 102 - 1
50 1.88 10-12 3.63 10-10 1.94 102 - 1
100 2.15 10-12 3.73 10-10 1.73 102 - 1
200 2.47 10-12 3.78 10-10 1.53 102 - 1
400
Eye
2.83 10-12 3.85 10-10 1.36 102 - 1
10 4.66 10-12 9.15 10-12 1.96 2.29 10-12 5.09 10-1
20 5.12 10-12 9.46 10-12 1.85 2.36 10-12 5.38 10-1
50 5.81 10-12 9.95 10-12 1.71 2.49 10-12 5.72 10-1
100 6.36 10-12 1.03 10-11 1.62 2.57 10-12 5.96 10-1
200 7.15 10-12 1.07 10-11 1.50 2.68 10-12 6.26 10-1
400
Breast
7.88 10-12 1.11 10-11 1.41 2.77 10-12 6.48 10-1
10 1.87 10-11 7.10 10-11 3.79 1.78 10-11 5.15 10-2
20 1.96 10-11 7.40 10-11 3.77 1.85 10-11 5.68 10-2
50 2.08 10-11 7.77 10-11 3.74 1.94 10-11 6.55 10-2
100 2.19 10-11 8.12 10-11 3.71 2.03 10-11 7.19 10-2
200 2.33 10-11 8.59 10-11 3.68 2.15 10-11 7.96 10-2
400
Thyroid
2.48 10-11 9.05 10-11 3.64 2.26 10-11 8.88 10-2
10 7.38 10-12 4.62 10-11 6.26 5.78 10-12 2.17 10-1
20 8.01 10-12 4.88 10-11 6.09 6.10 10-12 2.39 10-1
50 8.86 10-12 5.18 10-11 5.85 6.48 10-12 2.69 10-1
100 9.61 10-12 5.45 10-11 5.67 6.81 10-12 2.92 10-1
200 1.03 10-11 5.63 10-11 5.48 7.04 10-12 3.16 10-1
400
Thymus
1.13 10-11 5.97 10-11 5.26 7.46 10-12 3.43 10-1
10 2.22 10-12 3.39 10-12 1.53 2.04 10-12 8.40 10-2
20 2.51 10-12 3.82 10-12 1.52 2.29 10-12 8.51 10-2
50 2.90 10-12 4.43 10-12 1.53 2.66 10-12 8.14 10-2
100 3.23 10-12 4.97 10-12 1.54 2.98 10-12 7.74 10-2
200 3.62 10-12 5.59 10-12 1.54 3.35 10-12 7.38 10-2
400
Lung
4.09 10-12 6.35 10-12 1.55 3.81 10-12 6.94 10-2
Table 2. Dosimetric quantities per primary positive pion as a function of incident
energy for a monoenergetic pencil beam impinging at the centre of various target



























10 5.22 10-13 3.41 10-10 6.53 102 - 1
20 5.66 10-13 3.42 10-10 6.04 102 - 1
50 6.33 10-13 3.44 10-10 5.44 102 - 1
100 7.04 10-13 3.49 10-10 4.95 102 - 1
200 7.91 10-13 3.54 10-10 4.48 102 - 1
400
Eye
8.86 10-13 3.60 10-10 4.06 102 - 1
10 1.78 10-12 8.71 10-12 4.88 8.71 10-13 5.12 10-1
20 1.88 10-12 8.81 10-12 4.70 8.81 10-13 5.30 10-1
50 2.04 10-12 8.98 10-12 4.39 8.98 10-13 5.61 10-1
100 2.19 10-12 9.27 10-12 4.24 9.27 10-13 5.76 10-1
200 2.38 10-12 9.41 10-12 3.95 9.41 10-13 6.05 10-1
400
Breast
2.62 10-12 9.85 10-12 3.75 9.85 10-13 6.25 10-1
10 7.24 10-12 6.87 10-11 9.49 6.87 10-12 5.11 10-2
20 7.40 10-12 6.99 10-11 9.45 6.99 10-12 5.54 10-2
50 7.72 10-12 7.24 10-11 9.38 7.24 10-12 6.18 10-2
100 7.99 10-12 7.46 10-11 9.33 7.46 10-12 6.72 10-2
200 8.32 10-12 7.70 10-11 9.26 7.70 10-12 7.36 10-2
400
Thyroid
8.67 10-12 7.97 10-11 9.19 7.97 10-12 8.06 10-2
10 2.87 10-12 4.53 10-11 15.8 2.27 10-12 2.10 10-1
20 2.95 10-12 4.57 10-11 15.5 2.28 10-12 2.26 10-1
50 3.17 10-12 4.77 10-11 15.0 2.38 10-12 2.49 10-1
100 3.35 10-12 4.91 10-11 14.7 2.45 10-12 2.67 10-1
200 3.57 10-12 5.11 10-11 14.3 2.55 10-12 2.85 10-1
400
Thymus
3.78 10-12 5.23 10-11 13.8 2.62 10-12 3.08 10-1
10 8.57 10-13 3.30 10-12 3.85 7.93 10-13 7.50 10-2
20 9.08 10-13 3.51 10-12 3.87 8.43 10-13 7.22 10-2
50 9.99 10-13 3.89 10-12 3.90 9.34 10-13 6.49 10-2
100 1.09 10-12 4.26 10-12 3.90 1.02 10-12 6.38 10-2
200 1.19 10-12 4.65 10-12 3.92 1.12 10-12 5.87 10-2
400
Lung
1.31 10-12 5.14 10-12 3.92 1.23 10-12 5.92 10-2
Table 3. Dosimetric quantities per primary negative pion as a function of incident
energy for a monoenergetic pencil beam impinging at the centre of various target



























10 5.18 10-13 3.40 10-10 6.57 102 - 1
20 5.67 10-13 3.43 10-10 6.05 102 - 1
50 6.35 10-13 3.45 10-10 5.43 102 - 1
100 7.07 10-13 3.48 10-10 4.92 102 - 1
200 7.86 10-13 3.53 10-10 4.50 102 - 1
400
Eye
8.91 10-13 3.61 10-10 4.05 102 - 1
10 1.77 10-12 8.67 10-12 4.90 8.67 10-13 5.10 10-1
20 1.88 10-12 8.81 10-12 4.69 8.81 10-13 5.31 10-1
50 2.02 10-12 8.91 10-12 4.42 8.91 10-13 5.58 10-1
100 2.17 10-12 9.14 10-12 4.20 9.14 10-13 5.80 10-1
200 2.38 10-12 9.45 10-12 3.96 9.45 10-13 6.04 10-1
400
Breast
2.61 10-12 9.82 10-12 3.77 9.82 10-13 6.23 10-1
10 7.23 10-12 6.86 10-11 9.49 6.86 10-12 5.10 10-2
20 7.46 10-12 7.05 10-11 9.45 7.05 10-12 5.51 10-2
50 7.71 10-12 7.23 10-11 9.38 7.23 10-12 6.24 10-2
100 7.97 10-12 7.43 10-11 9.33 7.43 10-12 6.74 10-2
200 8.25 10-12 7.63 10-11 9.26 7.63 10-12 7.43 10-2
400
Thyroid
8.66 10-12 7.96 10-11 9.19 7.96 10-12 8.12 10-2
10 2.83 10-12 4.49 10-11 15.8 2.24 10-12 2.08 10-1
20 2.95 10-12 4.57 10-11 15.5 2.29 10-12 2.25 10-1
50 3.18 10-12 4.78 10-11 15.1 2.39 10-12 2.47 10-1
100 3.34 10-12 4.90 10-11 14.7 2.45 10-12 2.66 10-1
200 3.57 10-12 5.10 10-11 14.3 2.55 10-12 2.86 10-1
400
Thymus
3.82 10-12 5.28 10-11 13.8 2.64 10-12 3.09 10-1
10 8.45 10-13 3.27 10-12 3.87 7.85 10-13 7.11 10-2
20 9.09 10-13 3.52 10-12 3.88 8.46 10-13 6.95 10-2
50 9.96 10-13 3.88 10-12 3.90 9.32 10-13 6.37 10-2
100 1.09 10-12 4.26 10-12 3.91 1.02 10-12 6.18 10-2
200 1.19 10-12 4.67 10-12 3.92 1.12 10-12 5.95 10-2
400
Lung
1.32 10-12 5.18 10-12 3.92 1.24 10-12 5.81 10-2
Table 4. Dosimetric quantities per primary electron as a function of incident energy for




























10 2.06 10-13 2.95 10-10 1.43 103 - 1
20 2.15 10-13 2.95 10-10 1.37 103 - 1
50 2.27 10-13 2.95 10-10 1.30 103 - 1
100 2.35 10-13 2.95 10-10 1.25 103 - 1
200 2.42 10-13 2.95 10-10 1.22 103 - 1
400
Eye
2.45 10-13 2.95 10-10 1.20 103 - 1
10 7.19 10-13 6.67 10-12 9.28 3.34 10-13 5.36 10-1
20 7.38 10-13 6.69 10-12 9.06 3.34 10-13 5.47 10-1
50 7.61 10-13 6.70 10-12 8.80 3.35 10-13 5.60 10-1
100 7.77 10-13 6.70 10-12 8.62 3.35 10-13 5.69 10-1
200 7.87 10-13 6.70 10-12 8.51 3.35 10-13 5.75 10-1
400
Breast
7.94 10-13 6.70 10-12 8.44 3.35 10-13 5.78 10-1
10 3.01 10-12 5.67 10-11 18.8 2.83 10-12 6.01 10-2
20 3.03 10-12 5.67 10-11 18.7 2.84 10-12 6.29 10-2
50 3.05 10-12 5.69 10-11 18.7 2.85 10-12 6.65 10-2
100 3.06 10-12 5.70 10-11 18.6 2.85 10-12 6.90 10-2
200 3.07 10-12 5.70 10-11 18.6 2.85 10-12 7.10 10-2
400
Thyroid
3.07 10-12 5.70 10-11 18.6 2.85 10-12 7.20 10-2
10 1.15 10-12 3.68 10-11 32.1 9.21 10-13 1.97 10-1
20 1.16 10-12 3.69 10-11 31.7 9.23 10-13 2.07 10-1
50 1.19 10-12 3.70 10-11 31.2 9.26 10-13 2.19 10-1
100 1.20 10-12 3.71 10-11 30.9 9.28 10-13 2.27 10-1
200 1.21 10-12 3.71 10-11 30.6 9.27 10-13 2.35 10-1
400
Thymus
1.22 10-12 3.71 10-11 30.5 9.28 10-13 2.38 10-1
10 3.30 10-13 2.74 10-12 8.31 3.29 10-13 3.09 10-3
20 3.39 10-13 2.81 10-12 8.31 3.38 10-13 2.94 10-3
50 3.50 10-13 2.91 10-12 8.31 3.49 10-13 2.90 10-3
100 3.57 10-13 2.97 10-12 8.31 3.56 10-13 2.86 10-3
200 3.62 10-13 3.00 10-12 8.31 3.61 10-13 2.72 10-3
400
Lung
3.64 10-13 3.02 10-12 8.31 3.63 10-13 2.68 10-3
Table 5. Parameters AD, BD and AE, BE in equations (1) for 10˚—˚400 GeV protons. AD
and BD are in gray per primary particle, AE and BE are in sievert per primary particle.
ORGAN AD BD AE BE
Right eye 3.24 10-10 2.38 10-11 4.63 10-13 8.77 10-13
Thyroid 5.82 10-11 1.20 10-11 1.47 10-11 3.76 10-12
Thymus 3.80 10-11 8.19 10-12 4.88 10-12 2.40 10-12
Breast 7.89 10-12 1.22 10-12 2.52 10-12 2.00 10-12
Lung 1.45 10-12 1.82 10-12 1.01 10-12 1.15 10-12
Table 6. Parameters AD, BD and AE, BE in equations (1) for 10˚—˚400 GeV positive
pions. AD and BD are in gray per primary particle, AE and BE are in sievert per primary
particle.
ORGAN AD BD AE BE
Right eye 3.27 10-10 1.19 10-11 2.74 10-13 2.56 10-13
Thyroid 6.11 10-11 6.92 10-12 6.26 10-12 8.97 10-13
Thymus 4.01 10-11 4.64 10-12 2.23 10-12 5.81 10-13
Breast 7.93 10-12 6.84 10-13 1.21 10-12 5.14 10-13
Lung 2.05 10-12 1.14 10-12 5.47 10-13 2.82 10-13
Table 7. Parameters AD, BD and AE, BE in equations (1) for 10˚—˚400 GeV negative
pions. AD and BD are in gray per primary particle, AE and BE are in sievert per primary
particle.
ORGAN AD BD AE BE
Right eye 3.26 10-10 1.21 10-11 2.69 10-13 2.28 10-13
Thyroid 6.17 10-11 6.54 10-12 6.32 10-12 8.60 10-13
Thymus 3.95 10-11 4.99 10-12 2.17 10-12 6.14 10-13
Breast 7.89 10-12 6.91 10-13 1.20 10-12 5.14 10-13
Lung 1.99 10-12 1.18 10-12 5.29 10-13 2.91 10-13
Table 8. Parameters AD, BD and AE, BE in equations (1) for 10˚—˚400 GeV electrons. AD
and BD are in gray per primary particle, AE and BE are in sievert per primary particle.
ORGAN AD BD AE BE
Right eye 2.95 10-10 0 1.82 10-13 2.52 10-14
Thyroid 5.65 10-11 2.25 10-13 2.98 10-12 3.83 10-14
Thymus 3.66 10-11 1.97 10-13 1.11 10-12 4.54 10-14
Breast 6.66 10-12 1.62 10-14 6.76 10-13 4.78 10-14
Lung 2.58 10-12 1.81 10-13 3.11 10-13 2.19 10-14
Fig. 1. Dose to various target organs, DT, for a monoenergetic pencil beam of protons
with energy in the range 10˚—˚400 GeV. A fit according to the law DT˚=˚AD˚ +˚BD˚ log K
is shown. The parameters AD and BD are given in Table˚5.
Fig. 2. Dose to various target organs, DT, for a monoenergetic pencil beam of positive
pions with energy in the range 10˚—˚400 GeV. A fit according to the law
DT˚=˚AD˚+˚BD˚log K is shown. The parameters AD and BD are given in Table˚6.




















 Eye        Thymus
 Thyroid  Breast  Lung






















Positive Pion Energy (GeV)
 Eye        Thymus    Lung
 Thyroid  Breast
Fig. 3. Dose to various target organs, DT, for a monoenergetic pencil beam of negative
pions  with energy in the range 10˚—˚400 GeV. A fit according to the law
DT˚=˚AD˚ +˚BD˚ log K is shown. The parameters AD and BD are given in Table˚7.
Fig. 4. Dose to various target organs, DT, for a monoenergetic pencil beam of
electrons with energy in the range 10˚—˚400 GeV. A fit according to the law
DT˚=˚AD˚ +˚BD˚ log K is shown. The parameters AD and BD are given in Table˚8.
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Fig. 5. Effective dose E for various target organs, for a monoenergetic pencil beam of
protons with energy in the range 10˚—˚400 GeV. A fit according to the law
E˚=˚AE˚+˚BE˚log˚K is shown. The parameters AE and BE are given in Table˚5.
Fig. 6. Effective dose E for various target organs, for a monoenergetic pencil beam of
positive pions with energy in the range 10˚—˚400 GeV. A fit according to the law
E˚=˚AE˚+˚BE˚log˚K is shown. The parameters AE and BE are given in Table˚6.
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Fig. 7. Effective dose E for various target organs, for a monoenergetic pencil beam of
negative pions with energy in the range 10˚—˚400 GeV. A fit according to the law
E˚=˚AE˚+˚BE˚log˚K is shown. The parameters AE and BE are given in Table˚7.
Fig. 8. Effective dose E for various target organs, for a monoenergetic pencil beam of
electrons with energy in the range 10˚—˚400 GeV. A fit according to the law
E=˚AE˚+˚BE˚log˚K is shown. The parameters AE and BE are given in Table˚8.
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The results for lung and breast deserve a specific comment. Table 9 gives the
absorbed dose for the male  lung (the lung not covered by the breast) and for the
female  lung (the lung located under the breast), for the various particles and for the
five target organs. The ratio of the doses to the two lungs is shown in Figure˚9 for
protons (for pions the plots are very similar). This ratio is practically 1 when the target
organ is either the eye, the thyroid or the thymus: this is perfectly understandable as the
absorbed dose is due to scattered radiation and there is no reason that the two lungs are
irradiated differently. The situation is much different when either the (male) lung or the
breast are target. In this case Figure 9 shows that, when breast is irradiated, the ratio is
approximately 100, as the lung underneath in practice is also a target. When (the other)
lung is the target, the situation is reversed. For electrons, the behaviour for the various
organs is the same, but for breast and (male) lung the ratio is a factor of 10000 rather
than 100, because at GeV energies little energy is lost by collision processes.
From Figures 5˚—˚8 one sees that the effective dose increases with increasing wT
and with decreasing mass of the target organ. For breast, about half of the effective
dose is due to the breast itself and half to the lung, the other target organ. When a pencil
beam hits a selected target organ, the rest of the phantom also absorbs a certain dose
released by secondary radiation. The effective dose is thus the sum of a main
contribution from the target organ and several minor contributions from the other
tissues. The fraction of effective dose due to non-target organs is given in the last
column of Tables˚1˚—˚4 and shown for protons in Figure 10 (for pions the behaviour is
very similar) and for electrons in Figure 11. For lung (which is the male  lung not
covered by the breast, as explained above) most of the effective dose is due to the target
organ. For breast, a large fraction of the non-target dose is due to the underlying lung
which in practice is also a target, as stated above: for protons the fraction of effective
dose due to non-target organs is thus actually less than 10%. The values for lung and
breast in Figure˚10 are therefore coherent. For thymus a substantial fraction of E comes
from other organs because the target has a comparatively low wT-value. When eye is
the target organ there is no contribution to the effective dose from the target since there
is no associated wT-value. These observations are also valid for electrons, but for lung
this fraction is lower, about 3x10-3.
The curves of organ doses (Figures 1˚—˚4) and of effective dose (Figures 5˚—˚8)
versus energy are almost constant. This is reflected by the fits to the calculated values
given by equation (1), which is the superposition of two terms, one constant and one
weakly varying with energy. This behaviour can be explained in terms of stopping
powers. In fact, proton stopping powers decrease as a function of energy up to 1˚GeV
and are approximately constant above. In practice a very weak variation can still be
observed above 10˚GeV, which can explain the bend at the lower energy end of the
plots for hadrons. The collision energy loss for electrons is practically constant above a
few tens of MeV and this reflects in the very smooth behaviour of the dosimetric
quantities with beam energy.
4. Conclusions
The radiological hazard posed by a narrow beam of high-energy hadrons and
electrons was assessed by Monte Carlo calculations. Pencil beams of monoenergetic
protons, pions and electrons with energy in the range 10˚—˚400 GeV were made to
impinge on an anthropomorphic mathematical model to calculate values of effective
dose and absorbed doses in five representative target organs (right eye, breast, thyroid,
thymus and lung). Given the present lack of literature data on narrow beam dosimetry
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Table 9. Absorbed dose (Gy per primary particle) for the male  lung (the lung not covered by the breast) and for the female  lung (the lung
located under the breast), for the various particles and for the five target organs investigated.
Protons Positive pions Negative pions Electrons
Energy Target female  lung male  lung female  lung male  lung female  lung male  lung female  lung male  lung
10 1.73 10-14 1.45 10-14 1.28 10-14 1.06 10-14 1.26 10-14 1.05 10-14 7.96 10-17 6.34 10-17
20 1.85 10-14 1.46 10-14 1.29 10-14 1.07 10-14 1.26 10-14 1.18 10-14 7.37 10-17 6.06 10-17
50 2.16 10-14 1.75 10-14 1.35 10-14 1.18 10-14 1.37 10-14 1.14 10-14 7.34 10-17 5.27 10-17
100 2.33 10-14 1.86 10-14 1.50 10-14 1.26 10-14 1.46 10-14 1.31 10-14 6.87 10-17 4.87 10-17
200 2.39 10-14 2.14 10-14 1.75 10-14 1.38 10-14 1.68 10-14 1.44 10-14 6.28 10-17 3.93 10-17
400
Eye
2.78 10-14 2.43 10-14 1.91 10-14 1.57 10-14 2.01 10-14 1.59 10-14 5.13 10-17 3.41 10-17
10 3.61 10-12 6.63 10-14 3.51 10-12 5.34 10-14 3.47 10-12 5.33 10-14 3.20 10-12 4.02 10-16
20 4.20 10-12 7.62 10-14 3.86 10-12 5.41 10-14 3.87 10-12 5.50 10-14 3.35 10-12 3.99 10-16
50 5.11 10-12 8.36 10-14 4.47 10-12 5.63 10-14 4.40 10-12 5.39 10-14 3.54 10-12 3.29 10-16
100 5.85 10-12 9.13 10-14 4.93 10-12 5.81 10-14 4.94 10-12 5.88 10-14 3.67 10-12 2.83 10-16
200 6.89 10-12 9.91 10-14 5.64 10-12 6.83 10-14 5.64 10-12 6.59 10-14 3.76 10-12 2.55 10-16
400
Breast
7.94 10-12 1.10 10-13 6.42 10-12 7.22 10-14 6.38 10-12 7.15 10-14 3.81 10-12 2.09 10-16
10 3.98 10-14 3.98 10-14 3.26 10-14 3.44 10-14 3.32 10-14 3.33 10-14 2.71 10-16 2.71 10-16
20 4.48 10-14 4.68 10-14 3.52 10-14 3.43 10-14 3.47 10-14 3.43 10-14 2.61 10-16 2.58 10-16
50 5.27 10-14 5.13 10-14 3.67 10-14 3.81 10-14 3.68 10-14 3.62 10-14 1.99 10-16 2.05 10-16
100 5.69 10-14 5.66 10-14 3.81 10-14 3.84 10-14 3.71 10-14 3.89 10-14 1.94 10-16 2.10 10-16
200 6.57 10-14 6.13 10-14 4.11 10-14 4.12 10-14 3.85 10-14 3.90 10-14 1.82 10-16 1.93 10-16
400
Thyroid
6.78 10-14 6.90 10-14 4.36 10-14 4.57 10-14 4.46 10-14 4.14 10-14 1.41 10-16 1.55 10-16
10 2.15 10-13 2.10 10-13 1.79 10-13 1.83 10-13 1.77 10-13 1.75 10-13 3.16 10-15 3.30 10-15
20 2.49 10-13 2.43 10-13 1.80 10-13 1.87 10-13 1.79 10-13 1.80 10-13 3.15 10-15 2.99 10-15
50 2.76 10-13 2.74 10-13 1.92 10-13 1.97 10-13 1.94 10-13 1.99 10-13 2.78 10-15 2.95 10-15
100 3.05 10-13 3.07 10-13 2.10 10-13 2.08 10-13 2.07 10-13 2.06 10-13 2.67 10-15 2.81 10-15
200 3.35 10-13 3.34 10-13 2.24 10-13 2.32 10-13 2.30 10-13 2.31 10-13 2.66 10-15 2.53 10-15
400
Thymus
3.68 10-13 3.64 10-13 2.49 10-13 2.46 10-13 2.59 10-13 2.55 10-13 2.25 10-15 2.09 10-15
10 4.37 10-14 3.39 10-12 3.69 10-14 3.30 10-12 3.69 10-14 3.27 10-12 2.17 10-16 2.74 10-12
20 5.04 10-14 3.82 10-12 3.67 10-14 3.51 10-12 3.52 10-14 3.52 10-12 1.87 10-16 2.81 10-12
50 5.52 10-14 4.43 10-12 3.70 10-14 3.89 10-12 3.68 10-14 3.88 10-12 1.72 10-16 2.91 10-12
100 5.93 10-14 4.97 10-12 3.82 10-14 4.26 10-12 3.98 10-14 4.26 10-12 1.38 10-16 2.97 10-12
200 6.33 10-14 5.59 10-12 4.09 10-14 4.65 10-12 4.12 10-14 4.67 10-12 1.27 10-16 3.00 10-12
400
Lung
6.86 10-14 6.35 10-12 4.55 10-14 5.14 10-12 4.61 10-14 5.18 10-12 9.74 10-17 3.02 10-12
Fig. 9. Ratio of absorbed dose by the female  and male  lungs (see text) for protons
and for the five target organs investigated.
Fig. 10. Fraction of effective dose due to non-target organs for protons, for four of the
five target organs investigated (the eye has no associated wT-value).
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Fig. 11. Fraction of effective dose due to non-target organs for electrons, for four of
the five target organs investigated (the eye has no associated wT-value).
of high-energy particles, the five organs selected for the present study should provide a
fairly comprehensive picture of the different irradiation conditions which might be
encountered in an accident scenario. For a mixed beam of protons and positive pions,
the narrow beam data here presented for the different particles should be properly
weighted. The present results, along with the fits to the calculated values, should be of
help in post-accident dosimetry in case of an exposure where a different organ may be
involved and under different conditions than those here considered. The present
information are supplementary to existing data on conversion coefficients from fluence
to limiting quantities, calculated for a phantom exposed to broad beams. The strong
dependence of effective dose on the target organ is indeed a proof of the usefulness of
specific conversion coefficients for use in narrow beam dosimetry.
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